Diese Präsentation wurde erfolgreich gemeldet.
Wir verwenden Ihre LinkedIn Profilangaben und Informationen zu Ihren Aktivitäten, um Anzeigen zu personalisieren und Ihnen relevantere Inhalte anzuzeigen. Sie können Ihre Anzeigeneinstellungen jederzeit ändern.

190 virus infected monocyes

SHAPE Society

  • Loggen Sie sich ein, um Kommentare anzuzeigen.

  • Gehören Sie zu den Ersten, denen das gefällt!

190 virus infected monocyes

  1. 1. Procoagulant And Inflammatory Response of Virus-Infected Monocyes Provided by: Enrique Gurfinkel , MD, PhD Fundación Favaloro, Capital Federal, Buenos Aires, Argentina Editorial Slides VP Watch – November 13, 2002 - Volume 2, Issue 45
  2. 2. Introduction • Atherosclerosis is thought to be an inflammatory disease, but its origin still remains unanswered. • Chronic low-grade inflammation and combination of classical risk factors, plus novel risk factors such as the infectious burden seem to contribute to promote atherosclerosis.
  3. 3. Introduction • Monocytes play a prominent role in inflammation, coagulation and the ability to produce tissue factor and cytokines. • All of these factors, particularly the production of cytokines may contribute to acute coronary syndromes by eliciting plaque instability.
  4. 4. Background • During viral infections monocytes predominantly produce inflammatory cytokines. • In addition, continuing viral infection may sustain excess tissue factor production and exhaust the inhibitory effects of tissue factor pathway inhibitor.
  5. 5. As highlighted in VP Watch of this week, • Bouwman and co-workers tried to establish whether virus-infected monocytes initiate coagulation. And • To detect if the production of cytokines by monocytes may contribute to the chronic process of atherosclerosis in an in-vitro model.
  6. 6. Methods • Isolation of monocytes: monocytes obtained from fresh blood of healthy volunteers.
  7. 7. Methods • Preparation of virus stocks: Human embryonic lung, human epidermoid larynx carcinoma, and LLC-MK2 cells were cultured in Eagles´s minimum essential medium with Earle´s salts. • A clinical isolete of CMV was propagated in HEL cells • Chlamydia pneumoniae strain AR 39 was propagated in HEP-2 cells • Influenza A HIN1 86 Singapore was propagated in LLC-MK2 cells
  8. 8. Methods • Coagulation assay: Normal pooled plasma was prepared from the blood of nine healthy donors. • Cytokine assays: IL 6, 8, and 10 were measured in the supernatants of virus- infected monocytes.
  9. 9. It appeared that all strains could infect monocytes, but in all cases the infection was below 5% when undiluted virus stocks were used.  Fluorescence microscopy images of virus- infected monocytes. Magnification 200x after overnight incubation; Red background: uninfected monocytes. Green areas: virus-infected monocytes stained with FITC-labeled anti-virus antibodies. (a) CMV, specific staining of CMV in the nuclei of the infected cells. (b) Influenza A, smooth staining pattern of influenza A in monocytes. (c) Cp, more dense staining pattern of Cp in the cytoplasm of monocytes.
  10. 10. 80% of the monocytes were covered with activated CD41+ CD42+ Ficoll + VPT+ VPT+ Depletion Depletion Positive Selection CD41+ CD42+ 46% 78% 3%
  11. 11. CMV and Cp, like influenza, reduced the clotting time. The inititation of coagulation by virus-infected monocyes was a result of the expression of TF. Clottingtime(seconds) Uninfected monocytes Infected monocytes 140+-22.1 s 333+-22.1s
  12. 12. Infection with CMV and Cp induced the production of modest levels of IL6 and IL8, whereas infection with influenza A strongly stimulated the production of IL6 and 8. IL-6IL-8(pgml) CMV & Cp IL 6 1000 IL-8 H1N1 2000
  13. 13. Discussion • The results of the present study indicate that only small quantities of an infectious virus are needed to stimulate monocytes to exert considerable immunological effects.
  14. 14. Conclussions • The procoagulant activity of virus- infected monocytes is TF-dependent. • Influenza infection induced a pronounced expression of IL-6 and IL- 8, which could be associated with plaque rupture.
  15. 15. Questions • Is there any differences between the bacterial and viral infectious burden in promoting procoagulant activity? • Is it plausible to think that this could explain a systemic pro-thrombotic process after infection?
  16. 16. 1. Buja LM. Does atherosclerosis have an infectious etiology? Circulation 1996;94:872. 2. Burch GE, Tsui CY, Harb JM. Pathologic changes of aorta and coronary arteries of mice infected with Coxsackie B virus. Proc Soc Exp Biol Medl 1971;137:657–61. 3. Mosorin et al. Detection of Chlamydia pneumoniae-Reactive T lymphocytes in human atherosclerotic plaques of the carotid artery. Arterioscl Thromb Vasc Biol 2000;20:1061–7. 4. Blankenberg S, Rupprecht HJ, Bickel C, Espinola-Klein C, Rippin G et al. Cytomegalovirus infection with interleukine 6 response predicts cardiac mortality in patients with coronary artery disease. Circulation 2001;103 (24):2915–21. 5. Visseren FLJ, Bouwman JJM, Bouter KP, Diepersloot RJA, de Groot Ph, Erkelens DW. Procoagulant activity of endothelial cells after infection with respiratory viruses. Thromb Haemost 2000;84 (2):319–24. 6. Frostegard J, Ulfgren A, Nyberg P, Hedin U, Swedenborg J et al. Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage stimulating cytokines. Atherosclerosis 1999;145:33–43. 7. Neumann FJ, Ott I, Marx N, Luther T, Kenngott S et al. Effect of human recombinant Interleukin-6 and Interleukin-8 on Monocyte Procoagulant activity. Arteriosclerosis Thromb Vasc Biol 1997;17:3399–405. 8. Bouwman J. J. M. et al,. Eur J Clin Invest 2002; 32 (10): 759-766 References